Details for New Drug Application (NDA): 212083
✉ Email this page to a colleague
The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
Summary for 212083
Tradename: | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
Applicant: | Lannett Co Inc |
Ingredient: | acetaminophen; butalbital; caffeine |
Patents: | 0 |
Pharmacology for NDA: 212083
Physiological Effect | Central Nervous System Stimulation |
Suppliers and Packaging for NDA: 212083
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 212083 | ANDA | Lannett Company, Inc. | 0527-4094 | 0527-4094-37 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0527-4094-37) |
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 212083 | ANDA | Bryant Ranch Prepack | 63629-2087 | 63629-2087-1 | 100 CAPSULE in 1 BOTTLE, PLASTIC (63629-2087-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 325MG;50MG;40MG | ||||
Approval Date: | Dec 17, 2019 | TE: | AA | RLD: | No |
Complete Access Available with Subscription